Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8950131 | Life Sciences | 2018 | 30 Pages |
Abstract
Our key findings highlight the value of miR-494 inhibition as a therapeutic target for sepsis-associated ARDS, as a result of miR-494 accelerated ALI in rats with sepsis-associated ARDS through NQO1-mediated inactivation of Nrf2 signaling pathway.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yun Ling, Zheng-Zhao Li, Jian-Feng Zhang, Xiao-Wen Zheng, Zhuo-Qing Lei, Ru-Yan Chen, Ji-Hua Feng,